SCHEMBL4887183

SCHEMBL4887183

O=C(F)Cc1nn[nH]c1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.36
▸ GAA P10253 4/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ PLA2G10 O15496 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ LMNA P02545 2/20 0.33
▸ ABCC4 O15439 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ RET P07949 1/20 0.33
▸ PDGFRB P09619 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ RPS6KA3 P51812 1/20 0.33
▸ LIMK1 P53667 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16401560 0.75 TDP1 (0.38) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL11015928 0.74 DHFR (0.39) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL16050773 0.73 NR1H2 (0.42) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL701770 0.71 GRM5 (0.37) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL20028652 0.70 KDM4E (0.46) KDM4EGAAALDH1A1PLA2G10HPGD
SCHEMBL31518204 0.70 KDM4E (0.38) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL7544327 0.70 HPGD (0.36) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL11742762 0.70 LMNA (0.45) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL27873777 0.68 IKBKB (0.46) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL11810834 0.68 SMN1; SMN2 (0.44) KDM4EGAAALDH1A1HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242548-A1 Method of microencapsulating an agricultural active having a high melting point and uses for such materials MONSANTO TECHNOLOGY, L.L.C. (US) 2008-10-02 — — US disclosed
EP-1377161-B1 MICROENCAPSULATING OF AN AGRICULTURAL ACTIVE HAVING A HIGH MELTING POINT MONSANTO TECHNOLOGY LLC (US) 2006-06-21 — — EP disclosed
US-6992047-B2 Method of microencapsulating an agricultural active having a high melting point and uses for such materials MONSANTO TECHNOLOGY LLC (US) 2006-01-31 — — US disclosed
US-20050208089-A1 Method of microencapsulating an agricultural active having a high melting point and uses for such materials MONSANTO TECHNOLOGY, L.L.C. (US) 2005-09-22 — — US disclosed
EP-1377161-A1 MICROENCAPSULATING OF AN AGRICULTURAL ACTIVE HAVING A HIGH MELTING POINT Monsanto Technology LLC (US) 2004-01-07 — — EP disclosed
US-20030022791-A1 Method of microencapsulating an agricultural active having a high melting point and uses for such materials MONSANTO TECHNOLOGY, L.L.C. 2003-01-30 — — US disclosed
WO-2002082901-A1 MICROENCAPSULATING OF AN AGRICULTURAL ACTIVE HAVING A HIGH MELTING POINT MONSANTO TECHNOLOGY, LLC (US) 2002-10-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050208089-A1 Method of microencapsulating an agricultural active having a high melting point and uses for such materials LIPA, CEL, LIPE KDM4E 4114/4885GAA 59/4885ALDH1A1 3623/4885
US-20030022791-A1 Method of microencapsulating an agricultural active having a high melting point and uses for such materials LIPA, CEL, LIPE KDM4E 4114/4885GAA 59/4885ALDH1A1 3623/4885
US-20080242548-A1 Method of microencapsulating an agricultural active having a high melting point and uses for such materials LIPA, CEL, LIPE KDM4E 4114/4885GAA 59/4885ALDH1A1 3623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback